KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)

OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)

WARSAW, Ind., March 02, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Children’s Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida. The meeting offers a comprehensive program of lectures given an outstanding international faculty and cadaver labs centered on the cervical spine, lumbo-sacral junction, neuromonitoring, and various aspects of scoliosis.

Over the course of the event, the Company will highlight the unique benefits of its FIREFLY® Pedicle Screw Navigation Guides, which feature intuitive, 3D printed, patient-specific technology that eliminates the need for intraoperative radiation and the excessive fluoroscopy typically required with complex spinal reconstruction surgeries. Additionally, the Company will present its RESPONSE™ 4.5/5.0 Spine System, which offers an advanced system of instruments and implants with enhanced versatility to aid in optimal patient outcomes and allow surgeons to intervene at an earlier age and treat smaller statures.

In addition to showcasing its product offering, the Company will provide travel grants for senior residents and fellows to attend.

Mark Throdahl, OrthoPediatrics’ President & CEO, commented, “We are proud again to be the lead sponsor of ICSS, a CME course we initiated six years ago to advance our goal of becoming a leading resource for continuing medical education in pediatric orthopedics. We consider ICSS to be a superb forum that allows us to stay at the forefront of clinical developments and surgical techniques. The symposium will feature a wealth of programming geared toward scoliosis, one of the core pillars of our business, and we look forward to a productive event.”   

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 33 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit .

Investor Contacts

The Ruth Group

Tram Bui / Emma Poalillo

(646) 536-7035 / 7024

/

EN
02/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annu...

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including...

 PRESS RELEASE

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and...

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance First Quarter 2025 Revenue Increased 17% Year-over-Year WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ ...

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company’s 5th FDA approval in 2025. 3P Pediatric Plating Platform Hip System is a new plate and scre...

 PRESS RELEASE

OrthoPediatrics Corp. to Report First Quarter Financial Results on May...

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025 WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of Verte...

OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company’s 80th system designed to treat musculoskeletal issues in children. VerteGlide is a guided growth technology designed for children with Early Onset S...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch